| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Gerald W. McLaughlin is Director at ALLR and has filed Form 4s across 2 companies. Gerald W. McLaughlin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $140K at current prices.
The biggest single holding is ALLR (~$79K) as Director.
Gerald W. McLaughlin has 3 Form 4 filings on record from April 2021 to January 2026, across 2 companies: Director at Allarity Therapeutics (ALLR), 2025–2026; Director at Aytu Biopharma (AYTU), 2021.
The 3 reported transactions were 2 stock awards and 1 option or other derivative award.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria